Clinical Trial

Prospective Cohort Study of Local Recurrence After Radical Breast Cancer Resection

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to analyze clinicopathological characteristics and identify independent prognostic risk factors, as well as compare treatment outcomes in female patients aged ≥18 years with pathologically confirmed local recurrence of breast cancer after radical surgery (breast-conserving surgery or total mastectomy) without distant metastasis. The main questions it aims to answer are: What clinical and pathological factors independently affect progression-free survival (PFS) and overall survival (OS) of breast cancer patients with postoperative local recurrence? Do clinical features and long-term prognosis differ between patients with local recurrence after breast-conserving surgery and those after total mastectomy? Can we identify optimal individualized treatment regimens and suitable populations for re-breast-conserving surgery and postoperative radiotherapy after R0 resection? Participants will: Provide complete baseline demographic, initial clinicopathological, primary surgical and adjuvant treatment data, local recurrence lesion characteristics and post-recurrence treatment information via standardized case report forms; Undergo routine clinical examinations, imaging reviews and pathological rechecks as standard clinical practice; Receive standardized follow-up for at least 3 years through outpatient visits supplemented by telephone/WeChat contact to record disease progression, secondary local recurrence, distant metastasis, all-cause death and treatment adverse events.
Trial Details
NCT Number NCT07668362
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Conditions Breast Cancer
Enrollment 100 participants
Start Date 2026-07-20
Primary Completion 2031-12-30 (estimated)
Study Completion 2036-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-25